NCT07130669View on ClinicalTrials.gov

FACE Phase II (a Stage II Trial)

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

August 31, 2028

Conditions
MCISubjective Cognitive Decline (SCD)Mild Behavioral Impairment
Interventions
BEHAVIORAL

Cognitive Remediation

computerized cognitive training with a closed-loop human machine interface that monitor facial expression as engagement status of the person

BEHAVIORAL

Cognitive Remediation II

traditional computerized cognitive training

Trial Locations (1)

94304-0000

Stanford University CogT Lab, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT07130669 - FACE Phase II (a Stage II Trial) | Biotech Hunter | Biotech Hunter